Wyeth's 7-valent pneumococcal vacc registered in Russia

US drug major Wyeth says that its 7-valent pneumococcal conjugate  vaccine, Prevenar has been registered by the Russian Ministry of Health  and Social Development, the Roszdravnadzor, and is expected to be  commercially available later this year. Prevenar (also referred to as  PCV7), the global standard in pneumococcal disease prevention for  infants and young children, helps protect against the seven pneumococcal  serotypes contained in the vaccine that cause the majority of  pneumococcal disease worldwide, the company explains.